The Institute for Quality and Efficiency in Healthcare has issued a new report on Alzheimer's treatments. Comissioned by the German government, the report concludes:
- there is not enough proof that memantine (sold as Namenda in the U.S.) is effective in treating Alzheimer's
- cholinesterase inhibitors can "slightly delay" a decline in memory and thinking
- the evidence on ginkgo is mixed
- there's not enough proof that non-drug treatments are effective.